Ratification Date: 01/04/2025

Next Review Date: 01/04/2027

Interferon alfa (Roferon-A®, Viraferon®) – Chronic myelogenous leukaemia

Drug Name (Brand) Interferon alfa  (Roferon-A®, Viraferon®)
Indication Chronic myelogenous leukaemia
Traffic Light Classification Red
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

January 2013: Commissioned as a Hospital Only treatment by NHS Norfolk & Waveney in line with Cancer Network regimens.

 

March 2013: The TAG revised the previous Amber classification to Red (Hopistal Only) in line with the current commissioning position.

 

April 2013: NHS England SCG took over commissioning responsibility for this treatment.

 

 

 

 

Date of TAG recommendation / ratification 3/1/2013 Review Date 1/4/2027